From YMB “Barring unforeseen announcements, t
Post# of 148166
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”